- Global Pharma News & Resources

Press Releases - 2020-05-09

Date Title Company
09-May-2020 Coronavirus (COVID-19) Update: FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients U.S. Food and Drug Administration
09-May-2020 Lilly Receives U.S. FDA Approval for Retevmo(TM) (selpercatinib), the First Therapy Specifically for Patients with Advanced RET-Driven Lung and Thyroid Cancers Eli Lilly and Company